September 25, 2008

Takeda Pharmaceutical Company Limited

Takeda Established a New Company for Asian Sales & Marketing

Osaka, Japan, September 25, 2008 --- Takeda Pharmaceutical Company Limited ("Takeda") today announced the establishment of a wholly-owned subsidiary for overall Asian sales and marketing, Takeda Pharmaceuticals Asia Private Limited (TPAsia) in the Republic of Singapore.

TPAsia will supervise the overall business activities of Takeda’s sales and marketing subsidiaries in five Asian countries (Taiwan, Thailand, the Philippines, Indonesia and China)^[*1], and will promote the optimal strategies centered on sales and marketing for the Asian region from medium- and long-term perspectives.

At the same time, TPAsia will work closely with Takeda Clinical Research Singapore Private Limited, a wholly-owned subsidiary of Takeda for the center of clinical development in the Asia-Oceania region that is also located in Singapore, and promote further enhancement of our marketing and development function.

“The Asian pharmaceutical market is expected to grow more rapidly than other markets such as Japan, the U.S., and Europe,” said Yasuchika Hasegawa, President of Takeda. “We are aiming for the expansion of market share for each of the current Asian sales and marketing subsidiaries and for further entry into new markets through establishment of TPAsia, thereby realizing improved presence for Takeda in the Asian region.

[*1] Takeda Pharmaceuticals Taiwan, Ltd., Takeda (Thailand), Ltd., Takeda Pharmaceuticals (Philippines), Inc., P.T. Takeda Indonesia, Tianjin Takeda Pharmaceuticals Co., Ltd.M

<Outline of the new company>

1. Name:	Takeda Pharmaceuticals Asia Private Limited
2. Location:	Singapore
3. Capital:	6.7 million Singapore dollars

###